Maintaining our Gold Tier ranking, Mathys & Squire is delighted to be recommended in the 2026 edition of IAM Patent 1000: The World’s Leading Patent Professionals.
IAM is widely regarded as a leading authority in recognising excellent private practice patent expertise. Its rankings highlight top firms and practitioners through detailed qualitative research, considering elements such as previous work, technical capabilities and market presence.
We have been recognised as “a professional and well-respected firm, delivering high-quality legal work with a strong emphasis on responsiveness and efficiency.” Additionally, our team, “provides clear, practical advice and demonstrates a well-coordinated approach across matters. Overall, the experience of working with them is consistently positive thanks to their reliable and value-driven service.”
This year we have been ranked Gold Tier for prosecution in the United Kingdom: England and Wales, and have also been awarded the Silver Tier for the European Patent Office, highlighting the consistent, high quality service we provide for our clients.
Recommended individuals
In addition to our firm ranking, our Mathys & Squire attorneys have been recognised as Recommended Individuals.
Life Sciences & Chemistry team
- Chris Hamer is “attentive and brings a creative, well-informed approach to developing and protecting patent portfolios. He provides clients with practical advice and strong commercial insight, helping them define the right IP position and align it with investor expectations. He also supports assurance and due diligence activities, including freedom-to-operate analyses, and contributes to shaping overall business and portfolio strategy. His input plays a central role in strengthening companies’ development and long-term resilience”.
- Martin MacLean “works closely with scientists to review inventions, identify key technical details, and deliver high-quality patent applications. He supports drafting, prosecution, investor due diligence, and portfolio development. Providing pragmatic, strategically grounded advice, he combines credibility and professionalism with a clear, no-nonsense approach. From early-stage support through to core patent families, Martin helps underpin long-term success, with a strong ability to identify both technical significance and commercial potential”.
- “Michael Stott handles a wide-ranging practice spanning pharmaceuticals, materials science and polymer technologies, including responsibility for a significant global portfolio for Stratasys Inc. relating to 3D-printed materials.”
- Philippa Griffin “provides expert support in European patent prosecution and opposition proceedings, handling complex scientific subject matter with clarity and precision. She drafts and amends claims with strong legal and technical insight and represents clients with professionalism and composure. With a deep understanding of scientific and legal frameworks, Philippa delivers robust, well-reasoned filings. Her advocacy is strategic and credible, and her clear, collaborative communication supports the effective handling of complex matters.”
- “Craig Titmus supports clients through patent approvals and subsequent grants, delivering work that is both effective and commercially balanced. He demonstrates a strong ability to align costs with value, providing practical guidance throughout the process. Craig communicates complex IP concepts in a clear and accessible way, making them understandable for non-technical stakeholders and supporting informed decision-making.”
- “Anna Gregson works on complex biochemistry patent applications, including coordinating the co-filing of multiple related applications. She is diligent and detail-oriented, delivering high-quality work with consistency. Anna responds effectively to tight timelines, maintaining strong standards of service and reliability throughout.”
- “Stephen Garner is a trusted adviser to global pharmaceutical companies, handling the drafting, prosecution and opposition of patent portfolios, including the coordination of international strategies and supplementary protection matters, ensuring that clients’ key assets are both protected and effectively managed across jurisdictions.”
IT & Engineering team
- “Dani Kramer is a key figure in computing and software, advising on large-scale European portfolios and managing complex prosecution work, including technically demanding EPO examination and appeal proceedings across high-performance computing, semiconductors and networking technologies.”
- “Telecoms expertise is anchored by Alan MacDougall, who advises on the protection and defence of patent portfolios, including opposition work before the EPO, with a focus on preserving competitive advantage in fast-moving markets. “
- “James Pitchford strengthens the physical sciences offering through close collaboration with inventors and in-house teams, overseeing the drafting of original applications and coordinating international filing strategies to secure protection for technically sophisticated innovations.”
- “Andrew White brings cross-sector experience spanning medtech, software, telecoms and automotive technologies, with particular strength in deep tech. He has worked closely with Modini Limited to develop and prosecute a patent portfolio for its UAV technologies, covering areas such as avionics, engines and launch systems.”
- “Nicholas Fox offers a rare blend of legal and technical expertise as both solicitor and patent attorney, advising on UPC strategy and aligning opposition approaches across EPO and UPC proceedings to ensure consistency in multi-forum disputes.”
Managing Associates Alex Elder and Matthew Morton (Life Sciences & Chemistry) are also featured as Recommended Individuals.
You can see our ranking on the IAM website here.
